Home Uncategorized

Uncategorized

Latest

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book ‘The Nature of Drugs’

Tryp Therapeutics Partners with Clinlogix for Clinical Trial Support

Henrik Dahl’s Review of Pickard’s ‘The Rose of Paracelsus: On Secrets and Sacraments’

Markets for Feb 26: $AION +8.33%, $CYBN -19.19%, $FTRP -13.09%

Psychedelic Spotlight: Entheon Biomedical

Markets for Feb 24: $AION -18.75%, $TRIP +12.64%, $MCUR +11.53%

A New Path To Wealth: Navigating The Psychedelic Investment Landscape

February’s Psychedelic Capital Investigates Institutional Vs Retail Investor Impact

Psychedelic Guides with Ketan Patel of Next Healthcare Technologies Inc

Markets for Feb 20: $COOL +15.89%, $EHVVF -12.36%, $SILO +11.11%

Psychedelic Spotlight: The Conscious Fund

PsyCap Recap: 3 Key Takeaways From the Shroom Bloom Psychedelic Capital...

Markets for Feb 17: EHVVF +17.85%, MSET +15.04%, NM +8.93%

Psychedelic Guides with Joya Halls

PsyCap Recap: 3 Key Takeaways From the January 2021 Mindset Pharma...

12 3 4 Page 1 of 4

EDITOR PICKS

Psychedelic Bulletin: Microdosing Study Causes a Stir; COMPASS Secures 5th US...

Numinus Receives Conditional Approval to Graduate to the Toronto Stock Exchange

Numinus Announces Departure of Stacey Wallin

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

PTSF49 – MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians

Psychedelic Bulletin: Field Trip Raising $83m; NYU Langone Launches Psychedelic Medicine...

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.